Harbour Investments’s Organogenesis Holdings ORGO Stock Holding History

Harbour Investments’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.8K	Hold	6,521	–	–	﹤0.01%	3092
2026 Q1	$15.5K	Hold	6,521	–	–	﹤0.01%	3026
2025 Q4	$33.8K	Hold	6,521	–	–	﹤0.01%	2150
2025 Q3	$27.5K	Hold	6,521	–	–	﹤0.01%	2191
2025 Q2	$23.9K	Hold	6,521	–	–	﹤0.01%	2161
2025 Q1	$28.2K	Hold	6,521	–	–	﹤0.01%	2039
2024 Q4	$20.9K	Hold	6,521	–	–	﹤0.01%	2113
2024 Q3	$18.6K	Hold	6,521	–	–	﹤0.01%	2089
2024 Q2	$18.3K	Buy	6,521 +1,633	+33%	+$4.38K	﹤0.01%	1998
2024 Q1	$13.9K	Hold	4,888	–	–	﹤0.01%	2102
2023 Q4	$20K	Hold	4,888	–	–	﹤0.01%	1879
2023 Q3	$15.5K	Sell	4,888 -100	-2%	-$318	﹤0.01%	1862
2023 Q2	$16.6K	Hold	4,988	–	–	﹤0.01%	1830
2023 Q1	$10.6K	Hold	4,988	–	–	﹤0.01%	1992
2022 Q4	$13.4K	Hold	4,988	–	–	﹤0.01%	1837
2022 Q3	$24K	Hold	4,988	–	–	﹤0.01%	1564
2022 Q2	$24K	Buy	+4,988	New	+$30.7K	﹤0.01%	1564
2021 Q4	$2K	Sell	200 -617	-76%	-$6.55K	﹤0.01%	2418
2021 Q3	$12K	Buy	817 +617	+309%	+$9.58K	﹤0.01%	2574
2021 Q2	$3K	Hold	200	–	–	﹤0.01%	3263
2021 Q1	$4K	Buy	+200	New	+$2.71K	﹤0.01%	2999

Other funds holding ORGO

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Harbour Investments's ORGO Position: Q2 2026 in Review

Harbour Investments held its Organogenesis Holdings (ORGO) position steady in Q2 2026 at 6,521 shares worth $15.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3092.

Harbour Investments first reported a position in ORGO in Q1 2021 and has held it in 21 quarters since. The position peaked at $33.8K in Q4 2025. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

Harbour Investments held 6,521 shares of Organogenesis Holdings worth $15.8K as of Q2 2026.
Harbour Investments left its Organogenesis Holdings share count unchanged in Q2 2026.
Organogenesis Holdings made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #3092 holding.
Harbour Investments first reported a position in Organogenesis Holdings in Q1 2021 and has held it in 21 quarters since.
Harbour Investments's Organogenesis Holdings position peaked at $33.8K in Q4 2025.
136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.